WELLS FARGO & COMPANY/MN - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 90 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2024. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q2 2024$63,926
+4417.7%
13,718
+4816.8%
0.00%
Q1 2024$1,415
+83.8%
279
+1.8%
0.00%
Q4 2023$770
-25.5%
274
-23.9%
0.00%
Q3 2023$1,033
-17.2%
360
+45.7%
0.00%
Q2 2023$1,247
+3.0%
247
-61.5%
0.00%
Q1 2023$1,211
+181.6%
641
+168.2%
0.00%
Q4 2022$430
-57.0%
239
-67.5%
0.00%
Q3 2022$1,0000.0%735
-2.1%
0.00%
Q2 2022$1,000
-83.3%
751
-61.1%
0.00%
Q1 2022$6,000
-88.7%
1,930
-80.7%
0.00%
Q4 2021$53,000
-53.9%
10,005
-26.8%
0.00%
Q3 2021$115,000
-29.4%
13,668
+2.2%
0.00%
Q2 2021$163,000
-99.0%
13,379
-98.0%
0.00%
-100.0%
Q1 2021$16,250,000
-23.6%
669,854
+0.9%
0.00%
-20.0%
Q4 2020$21,270,000
+52.2%
663,633
+43.5%
0.01%
+25.0%
Q3 2020$13,978,000
+16.5%
462,387
+62.5%
0.00%
+33.3%
Q2 2020$11,996,000
+2542.3%
284,532
+1463.7%
0.00%
Q1 2020$454,00018,1960.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2024
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,014,858$5,581,0000.29%
NEA Management Company, LLC 3,449,845$9,556,0000.28%
Hawkeye Capital Management, LLC 243,009$673,0000.26%
DAFNA Capital Management LLC 313,600$869,0000.23%
Artal Group S.A. 1,646,517$4,561,0000.19%
MPM BioImpact LLC 239,888$664,0000.18%
RA Capital Management 2,589,904$7,174,0000.16%
Bellevue Group AG 3,293,000$9,122,0000.11%
Ikarian Capital, LLC 159,390$441,0000.06%
PDT Partners, LLC 66,168$183,0000.02%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders